Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-27BENLYSTA for Intravenous Injection / Subcutaneous Injection Special Drug Use Investigation
-
CLINICAL_TRIALS study record update · 2026-01-23An Open-Label Clinical Study of UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2026-01-22LUNELORD: A Descriptive, Prospective Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and QoL of Patients With LUpus NEphritis and Long-term ORgan Damage
-
CLINICAL_TRIALS study record update · 2026-01-16HLA Antibodies in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-13A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, or Rheumatoid Arthritis (Breakfree-1)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-12Study of Ultra-Fast Autologous CD19-Targeted Chimeric Antigen Receptor T (CAR- T) Therapy for Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-09A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2-Stage Trial to Evaluate Efficacy and Safety of Telitacicept Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
-
CLINICAL_TRIALS study record update · 2026-01-09A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
-
CLINICAL_TRIALS study record update · 2026-01-08Transforming Health Habits: Evaluating an Online Wellness Program for Individuals With Rheumatological Conditions
-
CLINICAL_TRIALS study record update · 2026-01-08Maternal Autoimmune Disease Research Alliance (MADRA) Registry
-
CLINICAL_TRIALS study record update · 2026-01-08Duke Lupus Registry
-
CLINICAL_TRIALS study record update · 2026-01-08The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants With Refractory B Cell-mediated Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-12-29Clinical Study of Core Blood-derived Anti-CD19 IL-10/IL15 CAR-NK in the Treatment of Refractory/Relapsed Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-12-26A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-23A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-22Phenotypic Characteristics and Transcriptomas of B Lymphocytes During Non Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-22An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences With Stress Strategies (BLESS) Study
-
CLINICAL_TRIALS study record update · 2025-12-19A Study to Evaluate the Safety and Efficacy of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-12-19A Phase 2 Clinical Study to Evaluate the Safety and Efficacy of Recombinant Humanized Monoclonal Antibody MIL62 Injection in the Treatment of Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2025-12-16Generating Evidence Study for Systemic Lupus Erythematosus Using Different Types of Methodologies
-
CLINICAL_TRIALS study record update · 2025-12-15A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-12REACT-01: Reversing Autoimmunity Through Cell Therapy
-
CLINICAL_TRIALS study record update · 2025-12-10An Observational Multicenter Retrospective-prospective Study of Patients With Active Moderate to Severe SLE
-
CLINICAL_TRIALS study record update · 2025-12-08A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-04A Randomized, Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL Pre-filled Syringe With 1 mL Pre-filled Syringe in Adult Participants With Autoimmune Disease